Related Experiment Video
Updated: Aug 9, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Correction: Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease
Ximing Liu1,2, Hongyu Zhang1,2, Changlong Hao1,2
1International Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China. hcl@jiangnan.edu.cn.
This correction clarifies the use of chiral selenium@cerium oxide (Se@CeO2) superparticles for Parkinson's disease treatment. The study details their potential therapeutic applications and synthesis methods.
Area of Science:
- Nanomaterials Science
- Biomedical Engineering
- Neuroscience
Context:
- Parkinson's disease is a progressive neurodegenerative disorder.
- Current treatments for Parkinson's disease have limitations.
- Nanoparticle-based therapies offer potential new avenues for treatment.
Purpose:
- To correct and clarify the findings regarding chiral Se@CeO2 superparticles.
- To provide accurate information on the synthesis and characterization of these nanoparticles.
- To re-evaluate their potential for ameliorating Parkinson's disease.
Summary:
- This is a correction notice for a previously published article.
- It addresses specific details related to the chiral Se@CeO2 superparticles.
- The correction ensures the scientific accuracy of the reported data and conclusions.
Impact:
- Ensures the integrity and reliability of scientific research in nanomaterials and neurodegenerative disease.
- Provides accurate information for researchers working on nanoparticle-based therapies for Parkinson's disease.
- Facilitates further development and application of Se@CeO2 superparticles in biomedical fields.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Chirality in Nature
Chirality at Nitrogen, Phosphorus, and Sulfur
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

